Cargando…

Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum

Leukocyte adhesion deficiency 1 (LAD-1) is a rare autosomal recessive disorder of leukocyte function. LAD-1 affects about 1 per 10 million individuals and is characterized by recurrent bacterial and fungal infections and depressed inflammatory responses despite striking blood neutrophilia. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Neha, Sodani, Ravitanya, Chandra, Jagdish, Singh, Varinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657233/
https://www.ncbi.nlm.nih.gov/pubmed/23716823
http://dx.doi.org/10.4103/0019-5154.108076
_version_ 1782270117949734912
author Thakur, Neha
Sodani, Ravitanya
Chandra, Jagdish
Singh, Varinder
author_facet Thakur, Neha
Sodani, Ravitanya
Chandra, Jagdish
Singh, Varinder
author_sort Thakur, Neha
collection PubMed
description Leukocyte adhesion deficiency 1 (LAD-1) is a rare autosomal recessive disorder of leukocyte function. LAD-1 affects about 1 per 10 million individuals and is characterized by recurrent bacterial and fungal infections and depressed inflammatory responses despite striking blood neutrophilia. Patients with the severe clinical form of LAD-1 express <0.3% of the normal amount of the β(2)-integrin molecules, whereas patients with the moderate phenotype may express 2-7%. Skin infection may progress to large chronic ulcers with polymicrobial infection, including anaerobic organisms. The ulcers heal slowly, require months of antibiotic treatment, and often require plastic surgical grafting. The diagnosis of LAD-1 is established most readily by flow cytometric measurements of surface CD11b in stimulated and unstimulated neutrophils using monoclonal antibodies directed against CD11b. Pyoderma gangrenosum (PG) is an uncommon condition characterized by recurrent sterile, inflammatory skin ulcers. Commonly, PG occurs in the context of inflammatory bowel disease or rheumatic, hematologic, or immunologic disorders. Here, we present a 5-year-old female with a long history of PG, which healed with atrophic scarring, who was ultimately diagnosed with leukocyte adhesion deficiency type 1 (LAD1). She had a good response to high-dose prednisone therapy (2 mg/kg) and was discharged after 3 weeks of admission but only to be re-admitted 3 weeks later with severe pneumonia. During hospital stay, she developed pneumothorax and pneumomediastinum and later succumbed to her illness.
format Online
Article
Text
id pubmed-3657233
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36572332013-05-28 Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum Thakur, Neha Sodani, Ravitanya Chandra, Jagdish Singh, Varinder Indian J Dermatol E-Case Report Leukocyte adhesion deficiency 1 (LAD-1) is a rare autosomal recessive disorder of leukocyte function. LAD-1 affects about 1 per 10 million individuals and is characterized by recurrent bacterial and fungal infections and depressed inflammatory responses despite striking blood neutrophilia. Patients with the severe clinical form of LAD-1 express <0.3% of the normal amount of the β(2)-integrin molecules, whereas patients with the moderate phenotype may express 2-7%. Skin infection may progress to large chronic ulcers with polymicrobial infection, including anaerobic organisms. The ulcers heal slowly, require months of antibiotic treatment, and often require plastic surgical grafting. The diagnosis of LAD-1 is established most readily by flow cytometric measurements of surface CD11b in stimulated and unstimulated neutrophils using monoclonal antibodies directed against CD11b. Pyoderma gangrenosum (PG) is an uncommon condition characterized by recurrent sterile, inflammatory skin ulcers. Commonly, PG occurs in the context of inflammatory bowel disease or rheumatic, hematologic, or immunologic disorders. Here, we present a 5-year-old female with a long history of PG, which healed with atrophic scarring, who was ultimately diagnosed with leukocyte adhesion deficiency type 1 (LAD1). She had a good response to high-dose prednisone therapy (2 mg/kg) and was discharged after 3 weeks of admission but only to be re-admitted 3 weeks later with severe pneumonia. During hospital stay, she developed pneumothorax and pneumomediastinum and later succumbed to her illness. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3657233/ /pubmed/23716823 http://dx.doi.org/10.4103/0019-5154.108076 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle E-Case Report
Thakur, Neha
Sodani, Ravitanya
Chandra, Jagdish
Singh, Varinder
Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum
title Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum
title_full Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum
title_fullStr Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum
title_full_unstemmed Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum
title_short Leukocyte Adhesion Defect Type 1 Presenting with Recurrent Pyoderma Gangrenosum
title_sort leukocyte adhesion defect type 1 presenting with recurrent pyoderma gangrenosum
topic E-Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657233/
https://www.ncbi.nlm.nih.gov/pubmed/23716823
http://dx.doi.org/10.4103/0019-5154.108076
work_keys_str_mv AT thakurneha leukocyteadhesiondefecttype1presentingwithrecurrentpyodermagangrenosum
AT sodaniravitanya leukocyteadhesiondefecttype1presentingwithrecurrentpyodermagangrenosum
AT chandrajagdish leukocyteadhesiondefecttype1presentingwithrecurrentpyodermagangrenosum
AT singhvarinder leukocyteadhesiondefecttype1presentingwithrecurrentpyodermagangrenosum